Malena Mahendran, MSc

Articles by Malena Mahendran, MSc

Real-World Users of Triple Therapy for Asthma in the US

ByNadia N. Hansel, MD,Carl B. Abbott, PharmD,Carlyne M. Averell, MS,Guillaume Germain, MSc,François Laliberté, MA,Malena Mahendran, MSc,Mei S. Duh, ScD,Russell A. Settipane, MD

February 9th 2024

This retrospective cohort study evaluated baseline demographics, clinical characteristics, and treatment patterns of US patients with asthma who newly initiated single- or multiple-inhaler triple therapy.

Latest Updated Articles

Real-World Users of Triple Therapy for Asthma in the US
February 9th 2024

Malena Mahendran, MSc

Articles by Malena Mahendran, MSc

Real-World Users of Triple Therapy for Asthma in the US

Latest Updated Articles

Trending on AJMC

Tavapadon for Parkinson Disease Approved by FDA

NCCN Journal Publishes Guidelines Update in Mantle Cell Lymphoma

DME Drug Remigromig Hits Primary End Point in Phase 3 Trial

Access and Innovation in North Carolina’s Research Triangle

Baricitinib Approved for Severe Alopecia Areata in Adolescents

Building a Cellular Therapy Program in the Community Oncology Setting: Perspectives and Lessons Learned

Malena Mahendran, MSc

Articles by Malena Mahendran, MSc

Real-World Users of Triple Therapy for Asthma in the US

Latest Updated Articles

Trending on AJMC

Tavapadon for Parkinson Disease Approved by FDA

NCCN Journal Publishes Guidelines Update in Mantle Cell Lymphoma

DME Drug Remigromig Hits Primary End Point in Phase 3 Trial

Access and Innovation in North Carolina’s Research Triangle

Baricitinib Approved for Severe Alopecia Areata in Adolescents